期刊文献+

肝细胞癌中精氨酸酶1和诱导型一氧化氮合成酶表达的临床意义及其相关性研究 被引量:5

Study on the clinical significance and correlation of arginase-1 and inducible nitric oxide synthase expression in hepatocellular carcinoma
原文传递
导出
摘要 目的探讨精氨酸酶1(Arg-1)和诱导型一氧化氮合成酶(iNOS)在肝细胞癌(HCC)中表达的相关性及临床意义。方法采用免疫组织化学法检测146例肝细胞癌及对应癌旁组织中Arg-1和iNOS的表达,采用χ2检验、Spearman等级相关分析、Kaplan-Meier生存分析及Cox多因素分析等统计学方法,分析两者表达的临床病理特征及其相关性和预后的关系。结果Arg-1和iNOS的阳性率分别为18.7%(23/123)和37.0%(54/146),明显低于癌旁组织100%(146/146)和93.8%(137/146),差异有统计学意义(χ^2=212.521,P<0.01,χ^2=104.276,P<0.01);两者表达存在一定的正相关性(r=0.331,P<0.01)。Arg-1低表达与术前血清甲胎蛋白(AFP)水平、肿瘤大小、分化程度、组织学类型及Edmondson分级相关,iNOS低表达与分化程度、Edmondson分级相关性(P<0.05)。Kaplan-Meier生存分析显示,患者无复发生存期(RFS)Arg-1(+)组>Arg-1(-)组以及Arg-1(+)iNOS(+)组>Arg-1(+)iNOS(-)组>Arg-1(-)iNOS(+)组>Arg-1(-)iNOS(-)组(P<0.05);COX多因素分析显示年龄、肿瘤大小、Edmondson分级、脉管癌栓与RFS显著相关(P值均<0.05)。结论在HCC中Arg-1与iNOS表达存在正相关性,两者均可反映HCC的恶性程度,两者降低/缺失表达可能协同参与了HCC的发生与发展,联合检测Arg-1与iNOS对HCC的分化程度及预后判断可能具有一定的意义。 Objective To investigate the clinical significance and correlation of arginase 1(Arg-1)and inducible nitric oxide synthase(iNOS)expression in hepatocellular carcinoma(HCC).Methods The expression of Arg-1and iNOS in 146 cases of hepatocellular carcinoma tissues and corresponding adjacent tissues was detected by immunohistochemistry.The clinicopathological characteristics and the correlation between the expressions and prognosis were determined by chi square test,Spearman’s rank correlation,Kaplan-Meier survival analysis and Cox regression analysis.Results The positive rates of Arg-1 and iNOS were 18.7%(23/123)and 37.0%(54/146),respectively,which was significantly lower than the adjacent tissues[100%(146/146)and 93.8%(137/146)]and the difference was statistically significant(χ^2=212.521,P<0.01,χ^2=104.276,P<0.01).There was a positive correlation between the both expression(r=0.331,P<0.01).Arg-1 low expression was correlated with preoperative serum alpha-fetoprotein(AFP)level,tumor size,differentiation degree,histological types and Edmondson’s grade.iNOS low expression was correlated with the differentiation degree and Edmondson’s grade(P<0.05).Kaplan Meier survival analysis showed that in patients with recurrence-free survival(RFs),Arg-1(+)group>Arg-1(-)group and Arg-1(+)iNOS(+)group>Arg-1(+)iNOS(-)group>Arg-1(-)iNOS(-)group(P<0.05).Cox multivariate analysis showed that age,tumor size,Edmondson’s grade,vascular tumor emboli were significantly correlated with RFs(P<0.05).Conclusion There is a positive correlation between Arg-1 and iNOS expressions in HCC,and both may reflect the HCC malignant degree.The reduced/absent expression of both may participate in the occurrence and development of HCC.The combined detection of Arg-1 and iNOS on HCC may have certain significance for the judgment of differentiation degree and prognosis.
作者 陶璇 王斌 陈虹 黄爱民 叶韵斌 黄传钟 高凌云 Tao Xuan;Wang Bin;Chen Hong;Huang Aimin;Ye Yunbin;Huang Chuanzhong;Gao Lingyun(Department of Pathology,Institute of Oncology,Fujian Medical University,Fuzhou,350004,China;Department of Pathology,The First Affiliated Hospital of Fujian Medical University,Fuzhou,350005,China;Immuno-Oncology Laboratory of Fujian Provincial Cancer Hospital,Fujian Medical University Teaching Hospital,Fujian Provincial Key Laboratory of Translational Cancer Medicine,Fuzhou,350014,China)
出处 《中华肝脏病杂志》 CAS CSCD 北大核心 2020年第11期924-929,共6页 Chinese Journal of Hepatology
基金 福建省中青年教师教育科研项目(科技类)(JAT170237) 福建师范大学开放课题(JYG1909)。
关键词 肝细胞癌 精氨酸酶1 诱导型一氧化氮合成酶 分化 预后 Hepatocelluar carcinoma Arginase-1 Inducible Nitric Oxide Synthase Differentiation Prognosis
  • 相关文献

参考文献2

二级参考文献27

  • 1Bamberger AM, Riethdorf L, Milde-Langosch K, et al. Strongly reduced expression of the cell cycle inhibitor p27 in endometrial neoplasia. Virchows Arch, 1999, 434: 423-428.
  • 2Robertson KA, Bullock HA, Xu Y, et al. Altered expression of Apel/ ref-1 in germ cell tumors and overexpression in NT2 ceils confers resistance to bleomycin and radiation. Cancer Res, 200, 61: 2220- 2225.
  • 3Yang S, Irani K, Heffron SE, et al. Alterations in the expression of the apurinic/apyrimidinic endonuclease-1/redox factor-1 (APE/Refl) in human melanoma and identification of the therapeutic potential of resveratrol as an APE/Ref- 1 inhibitor. Mol Cancer Ther, 2005, 4: 1923-1935.
  • 4臧盛兵,黄爱民,高凌云,刘景丰,丁毅,高美钦.手工制作组织芯片方法的改良及其在肝细胞癌研究中的应用[J].中国组织化学与细胞化学杂志,2007,16(3):385-388. 被引量:9
  • 5Weng–Lung Ma,Cheng–Lung Hsu,Ming–Heng Wu,Chun–Te Wu,Cheng–Chia Wu,Jiann–Jyh Lai,Yuh–Shan Jou,Chun–Wei Chen,Shuyuan Yeh,Chawnshang Chang.Androgen Receptor Is a New Potential Therapeutic Target for the Treatment of Hepatocellular Carcinoma[J].Gastroenterology.2008(3)
  • 6Lindsey A. Torre,Freddie Bray,Rebecca L. Siegel,Jacques Ferlay,Joannie Lortet‐Tieulent,Ahmedin Jemal.Global cancer statistics, 2012[J]. CA: A Cancer Journal for Clinicians . 2015 (2)
  • 7Donald MaxwellParkin.??The global health burden of infection‐associated cancers in the year 2002(J)Int. J. Cancer . 2006 (12)
  • 8Frank J Gonzalez.??The peroxisome proliferator-activated receptor α (PPARα): role in hepatocarcinogenesis(J)Molecular and Cellular Endocrinology . 2002 (1)
  • 9Latifa Bakiri,Erwin F. Wagner.??Mouse models for liver cancer(J)Molecular Oncology . 2013
  • 10Kwang Il Kim,Yong Jin Lee,Tae Sup Lee,Inho Song,Gi Jeong Cheon,Sang Moo Lim,June-Key Chung,Joo Hyun Kang.??In Vitro Radionuclide Therapy and In Vivo Scintigraphic Imaging of Alpha-Fetoprotein-Producing Hepatocellular Carcinoma by Targeted Sodium Iodide Symporter Gene Expression(J)Nuclear Medicine and Molecular Imaging . 2013 (1)

共引文献8

同被引文献46

引证文献5

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部